Crescita Therapeutics Financials

Crescita Therapeutics Stock Summary

Crescita Therapeutics competes with Cannara Biotech, Knight Therapeutics, Bionoid Pharma, and HLS Therapeutics. Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. Crescita Therapeutics Inc. was incorporated in 2016 and is headquartered in Laval, Canada. Crescita Therapeutics is traded on OTC Exchange in the United States.

Crescita Therapeutics Key Financial Ratios

There are many critical financial ratios that Crescita Therapeutics' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Crescita Therapeutics reports annually and quarterly.

Crescita Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Crescita Therapeutics's current stock value. Our valuation model uses many indicators to compare Crescita Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Crescita Therapeutics competition to find correlations between indicators driving Crescita Therapeutics's intrinsic value. More Info.Crescita Therapeutics is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers reporting about  0.71  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Crescita Therapeutics is roughly  1.40 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Crescita Therapeutics' earnings, one of the primary drivers of an investment's value.

Crescita Therapeutics Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Crescita Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Crescita Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Crescita Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Crescita Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Crescita Therapeutics's daily price indicators and compare them against related drivers.

When running Crescita Therapeutics' price analysis, check to measure Crescita Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crescita Therapeutics is operating at the current time. Most of Crescita Therapeutics' value examination focuses on studying past and present price action to predict the probability of Crescita Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crescita Therapeutics' price. Additionally, you may evaluate how the addition of Crescita Therapeutics to your portfolios can decrease your overall portfolio volatility.